Earnings Analysis Of Abbott Laboratories (ABT)

Lloyd Doyle
January 12, 2018

The company saw 4.34 million shares trade hands over the course of the day. After $0.66 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 10.61% EPS growth. Beaumont Financial Partners Llc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $102.26B market cap company. The stock decreased 0.59% or $0.25 during the last trading session, reaching $42.47. The shares were sold at an average price of $54.92, for a total transaction of $1,555,279.48.

Mountain Pacific Invest Advisers Id owns 0.2% invested in Abbott Laboratories (NYSE:ABT) for 33,851 shares. It has underperformed by 11.43% the S&P500.

COPYRIGHT VIOLATION NOTICE: "Verity & Verity LLC Has $7.27 Million Stake in Abbott Laboratories (ABT)" was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. The stock increased 0.17% or $0.1 during the last trading session, reaching $58.92. About 3.28 million shares traded. Ford Motor Company (NYSE:F) has declined 16.63% since January 11, 2017 and is downtrending. Archford Cap Strategies Limited Company invested in 0.2% or 9,947 shares. ABT has a beta of 1.55 and MDT's beta is 0.93. It fall, as 40 investors sold CF shares while 147 reduced holdings. Vantage Investment Advisors LLC grew its position in shares of Abbott Laboratories by 103.4% during the second quarter. Signaturefd Ltd Co reported 14,812 shares. Busey Tru holds 0.16% or 25,824 shares in its portfolio. Family Legacy Inc. acquired a new position in shares of Abbott Laboratories in the first quarter valued at approximately $203,000. Moreover, Deroy And Devereaux Private Inv Counsel has 0.03% invested in Abbott Laboratories (NYSE:ABT) for 4,612 shares. Ftb Advsr accumulated 61,685 shares. Robertson Opportunity Cap has 1.8% invested in CF Industries Holdings, Inc. Lipe Dalton has 1,980 shares. Bridgewater Assocs Limited Partnership has invested 0.01% in The Allstate Corporation (NYSE:ALL). (NASDAQ:AAPL). Odey Asset Grp Limited invested in 0.39% or 28,000 shares. Evercore ISI began coverage on shares of Abbott Laboratories in a report on Wednesday, January 3rd. Following the sale, the executive vice president now directly owns 142,082 shares in the company, valued at $7,986,429.22. Vanguard Group Inc. lifted its position in Abbott Laboratories by 2.6% during the second quarter.

Analysts await Apple Inc. (NYSE:CF) to report earnings on February, 21. The company's quarterly revenue was up 28.8% compared to the same quarter last year. equities research analysts expect that Abbott Laboratories will post 2.5 earnings per share for the current fiscal year. ALL's profit will be $584.89M for 15.42 P/E if the $1.63 EPS becomes a reality. Leerink Swann also issued estimates for Abbott Laboratories' Q4 2017 earnings at $0.74 EPS, Q3 2018 earnings at $0.78 EPS, FY2018 earnings at $2.85 EPS, FY2019 earnings at $3.17 EPS and FY2021 earnings at $3.93 EPS.

Since August 1, 2017, it had 0 insider buys, and 6 sales for $22.86 million activity. The insider Fussell Stephen R sold $9.73 million.

Since August 1, 2017, it had 0 insider purchases, and 6 selling transactions for $22.86 million activity. The company was maintained on Thursday, July 14 by Jefferies. Cf Inds Hldgs Inc now has $9.91B valuation.


Among 52 analysts covering Apple Inc. Therefore 62% are positive. F&M Bank had 56 analyst reports since August 7, 2015 according to SRatingsIntel. As per Monday, July 31, the company rating was maintained by UBS. The stock of Assurant, Inc. The rating was maintained by Keefe Bruyette & Woods on Wednesday, August 2 with "Hold". Citigroup upgraded The Allstate Corporation (NYSE:ALL) on Tuesday, December 1 to "Neutral" rating. RBC Capital Markets maintained it with "Outperform" rating and $51 target in Friday, October 9 report. The stock has "Equal-Weight" rating by Barclays Capital on Wednesday, January 6. Brean Capital maintained Apple Inc. The firm earned "Buy" rating on Monday, June 26 by RBC Capital Markets. (NASDAQ:AAPL) rating on Monday, June 12. Jefferies has "Buy" rating and $52 target. Morgan Stanley upgraded the shares of ABT in report on Tuesday, January 2 to "Overweight" rating. Pacific Crest maintained Apple Inc. Pacific Crest has "Overweight" rating and $127 target.

Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It dropped, as 47 investors sold Abbott Laboratories shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes.

Shares of Abbott Laboratories (NYSE:ABT) traded up 0.22% during trading on Friday, hitting $41.05. Raymond James Na holds 178,671 shares. Engines Advisors Ltd Liability has invested 0.3% in Abbott Laboratories (NYSE:ABT). Cubist Systematic Strategies Llc reported 18,765 shares.

In other Abbott Laboratories news, insider Alejandro D. Wellisch sold 2,153 shares of the business's stock in a transaction on Wednesday, November 22nd. Wilbanks Smith And Thomas Asset Mgmt Lc reported 24,778 shares stake. 184,801 were accumulated by Oregon Pub Employees Retirement Fund. Centurylink Investment Mngmt reported 16,212 shares. 11,058 were accumulated by Holderness. Martingale Asset Mgmt Lp reported 0% stake.

While talking about Performance of the Stock, Abbott Laboratories now has a Weekly performance of 0.22%, monthly performance percentage is 7.73 percent, Quarterly performance is 7.79 percent, 6 months performance shows a percent value of 22.37% and Yearly Performance is 44.62 percent. Therefore 48% are positive. According to these analysts, the Low Revenue Estimate for Abbott Laboratories is 7.29 Billion and the High Revenue Estimate is 7.49 Billion. Guggenheim maintained the shares of ABT in report on Tuesday, January 2 with "Buy" rating. Piper Jaffray maintained CyberArk Software Ltd. (NASDAQ:CYBR) on Tuesday, August 8 with "Buy" rating. Salvadori Daniel Gesua Sive also sold $3.31M worth of Abbott Laboratories (NYSE:ABT) on Tuesday, September 26.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER